Charles B, Schild P, Steer P, Cartwright D, Donovan T
Department of Pharmacy, University of Queensland, St. Lucia, Australia.
Dev Pharmacol Ther. 1993;20(3-4):205-10. doi: 10.1159/000457564.
The single-dose pharmacokinetics of dexamethasone were studied in 7 extremely low birth weight infants of mean (+/- SD) gestational age 25.6 +/- 0.5 weeks suffering bronchopulmonary dysplasia. A mean peak dexamethasone concentration of 250.5 +/- 70.7 ng/ml was obtained following an intravenous bolus dose (0.369 +/- 0.04 mg/kg dexamethasone) of dexamethasone sodium phosphate. Dexamethasone was measured in plasma by HPLC. Mean clearance (0.143 +/- 0.028 litres/kg/h) was approximately half that reported previously in children and adults, while the half-life (9.26 +/- 3.34 h) was 2- to 3-fold longer than in these patients. The volume of distribution (1.9 +/- 0.483 litres/kg) was larger than reported in a previous study in adults, but was similar to that determined in pediatric and adult patients in another study.
研究了7例平均(±标准差)胎龄25.6±0.5周、患有支气管肺发育不良的极低出生体重儿地塞米松的单剂量药代动力学。静脉推注磷酸地塞米松(0.369±0.04mg/kg地塞米松)后,地塞米松的平均峰值浓度为250.5±70.7ng/ml。采用高效液相色谱法测定血浆中的地塞米松。平均清除率(0.143±0.028升/千克/小时)约为先前报道的儿童和成人的一半,而半衰期(9.26±3.34小时)比这些患者长2至3倍。分布容积(1.9±0.483升/千克)比先前一项成人研究中报道的要大,但与另一项研究中儿科和成人患者测定的结果相似。